About

Ginny Blocki serves as Senior Vice President, Strategy at embecta, where she is accountable for developing the company's strategy, partnership and alliance growth initiatives, seeking new avenues to drive embecta's future growth and assessing new business development opportunities. She joined the organization in 2021 as Senior Vice President, Global Marketing and Product Management.

Prior to embecta, Ginny was with Baxter as the Head of U.S. Medication Delivery Marketing, covering Infusion Systems, IV Fluids, Disposables and Pharmacy WorkFlow Manager. Before Baxter she was Vice President, Specialty Products at Assertio Therapeutics, where she led marketing and sales efforts and played a key role in product development of a priority asset and multiple business development endeavors. Earlier she served as Head of Global Marketing, Molecular Diagnostics at Abbott Laboratories, and as Vice President, Head of Global Marketing, Immunology at Baxter and Baxalta (the spin-off from Baxter).

Ginny holds a Bachelor of Science degree in finance from Indiana University and completed the Executive Scholar Program in General Management at the Kellogg School of Management, Northwestern University.

Roles

Embecta Corp.
Senior Vice President, Strategy · Current role
2021–present
BD (Becton, Dickinson and Company)
Senior Vice President, Product Management and Global Marketing of Diabetes Care · Held since October 2021, until the Separation.
Baxter International Inc. (NYSE: BAX)
Head of U.S. medication delivery marketing · Until 2021.
Assertio Therapeutics, Inc. (Nasdaq: ASRT)
Leadership roles · Until 2020.
Abbott Laboratories (NYSE: ABT)
Leadership roles · Until 2018.
Baxalta
Leadership roles · Baxalta was later acquired by Shire PLC ADR (Nasdaq: SHPC).
Baxter
Head of U.S. Medication Delivery Marketing · Covered Infusion Systems, IV Fluids, Disposables and Pharmacy WorkFlow Manager.
Assertio Therapeutics, Inc. (Nasdaq: ASRT)
Vice President, Specialty Products · Led marketing and sales efforts and played a key role in product development of a priority asset and multiple business development endeavors.
Abbott Laboratories (NYSE: ABT)
Head of Global Marketing, Molecular Diagnostics · Oversaw and led all commercial activities.
Baxter and Baxalta
Vice President, Head of Global Marketing, Immunology · Played a vital role in the Global Immunology business; Baxalta was the spin-off from Baxter.

Also at Embecta Corp.

Related

See how VectorShift works for your firm

Request Demo